Emily J. Reppert

Emily J. Reppert

Auto-generated profile, based on publicly available information

Emily J. Reppert

Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2019 in Journal of Veterinary Pharmacology and Therapeutics
Verified
Journal Article
Closed access
PDF file
EREmily J. Reppert
Emily J. Reppert
MKMichael Kleinhenz
Michael Kleinhenz
SMShawnee R. Montgomery
Shawnee R. Montgomery
HBHeather N. Bornheim
Heather N. Bornheim
GMGeraldine Magnin
Geraldine Magnin
Johann CoetzeeJohann Coetzee
Johann Coetzee

6 February 2021 in Animals
Verified
Journal Article
Open access
PDF file
AVAbbie Viscardi
Abbie Viscardi
EREmily J. Reppert
Emily J. Reppert
MKMichael Kleinhenz
Michael Kleinhenz
PWPayton Wise
Payton Wise
Zhoumeng LinZhoumeng Lin
Zhoumeng Lin
Johann CoetzeeJohann Coetzee
Johann Coetzee
The amount of scientific data evaluating sheep pain responses after analgesia treatment is limited. The aims of this study were to compare the efficacy of flunixin meglumine (FLU) and meloxicam (MEL) at relieving post-surgical pain in sheep and to evaluate the utility of the Sheep Grimace Scale (SGS). Thirty ewes were assigned to one of three treatment groups: oral MEL or intravenous FLU to manage pain associated with a laparotomy procedure, or a non-surgical control (CON) group. Behavior and physiologic outcome measures were collected pre-procedure and up to 48 h post-procedure. There were no significant differences in behavior, gait, degree of inflammation or pain around the surgical site when MEL and FLU sheep were compared, suggesting that both drugs provided similar levels of analgesia. Significant differences in behavior, gait, abdominal inflammation and pain were found when surgical sheep were compared to non-surgical controls. More work is needed to characterize the amount of pain relief provided by MEL and FLU. The SGS had moderate reliability between scorers; however, the results were inconsistent with the other study outcome measures. The SGS may have some utility as a pain assessment tool but should be used in conjunction with other pain measures.

30 November 2018 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
RORachel E. Oman
Rachel E. Oman
EREmily J. Reppert
Emily J. Reppert
RSRobert N. Streeter
Robert N. Streeter
MJMeredyth Jones
Meredyth Jones
Background Obstructive urolithiasis commonly affects male goats. Perineal urethrostomy (PU) can be a permanent treatment option but is generally considered undesirable because of the risk of stricture of the urethral stoma. Limited information exists regarding long‐term outcome and complications in goats undergoing PU for treatment of obstructive urolithiasis. Objectives To determine short‐term and long‐term outcome and complications in goats undergoing PU for treatment of obstructive urolithiasis. Animals Twenty‐five client‐owned goats. Methods Multi‐institutional retrospective case series. Results Of the 25 goats, 13 (52%) were alive at the time of follow‐up. Mean time from surgery to follow‐up was 34 months (range, 4‐65). Nine goats (36%) died between discharge and follow‐up with a mean survival time of 46 days (range, 5‐120). Cause of death in 7 of 9 (78%) goats was related to urolithiasis. Goats treated by use of a modified proximal perineal urethrostomy (MPPU) were significantly more likely to survive at least 150 days postoperatively (P < .01). The most common postoperative complications were hemorrhage (10/25 [40%]) and surgical site infection (3/25 [12%]). Hemorrhage was significantly associated with MPPU (P < .0001). Stricture of the surgical stoma occurred in 7 of 22 (32%) discharged goats. Mean time to stricture was 65 days (range, 10‐240). Conclusions and Clinical Importance Perineal urethrostomy can provide effective long‐term resolution of obstructive urolithiasis in goats. Re‐obstruction or stricture seems most likely within the 1st 2 months after surgery. MPPU may provide better long‐term results but should be approached cautiously because it can be associated with life‐threatening hemorrhage.

2 December 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
ATAlyssa Toillion
Alyssa Toillion
EREmily J. Reppert
Emily J. Reppert
Raghavendra AmachawadiRaghavendra Amachawadi
Raghavendra Amachawadi
KOKC Olson Olson
KC Olson Olson
Johann CoetzeeJohann Coetzee
Johann Coetzee
Kathryn E. ReifKathryn E. Reif
Kathryn E. Reif
Anaplasmosis is an economically-significant, hemolytic, tick-borne disease of cattle caused by Anaplasma marginale which can cause clinical anemia and death. Current control options are limited, and FDA-approved antimicrobial control options do not have a defined duration of use. A practical and routinely used anaplasmosis control method involves feeding free-choice chlortetracycline (CTC)-medicated mineral to pastured cattle for several months. Constant antimicrobial use poses the risk of expediting the development and dissemination of antimicrobial resistance in off-target commensal bacteria in the bovine gastrointestinal tract. The objective of this study was to determine the CTC-susceptibility of Escherichia coli isolated from anaplasmosis endemic beef cattle herds provided different FDA-approved free-choice CTC-medicated mineral formulations, all intended to provide cattle a dosage of 0.5 to 2.0 mg CTC/lb bodyweight per day. A closed-herd, comprised of Hereford-Angus cows, naturally endemic for anaplasmosis, were grazed in five different pastures with one herd serving as an untreated control group. The other cattle herds were randomly assigned one of four FDA-approved CTC-medicated mineral formulations (700, 5000, 6000, and 8000 g CTC/ton) labeled for “the control of active anaplasmosis” and provided their respective CTC-medicated mineral formulation for five consecutive months. Fecal samples were collected monthly from a subset of cows (n = 6 or 10) per pasture. Fecal samples were cultured for E. coli isolates and the minimal inhibitory concentration of CTC was determined. Baseline CTC-susceptibility of E. coli was variable among all treatment and control groups. The susceptibility of E. coli isolates was significantly different between study herds over the treatment period (p = 0.0037 across time and 0.009 at the final sampling time). The interaction between study herds and treatment period was not significant (p = 0.075).

29 July 2019 in Journal of Veterinary Pharmacology and Therapeutics
Verified
Journal Article
Closed access
PDF file
EREmily J. Reppert
Emily J. Reppert
MKMichael Kleinhenz
Michael Kleinhenz
SMShawnee R. Montgomery
Shawnee R. Montgomery
JHJared Heiman
Jared Heiman
ASAmanda Sura
Amanda Sura
Johann CoetzeeJohann Coetzee
Johann Coetzee

1 November 2016 in American Journal of Veterinary Research
Verified
Journal Article
Closed access
EREmily J. Reppert
Emily J. Reppert
RSRobert N. Streeter
Robert N. Streeter
KSKatharine M. Simpson
Katharine M. Simpson
JTJared D. Taylor
Jared D. Taylor
OBJECTIVE To identify and evaluate 3 types of angiographic catheters for retrograde urinary bladder catheterization in healthy male goats. ANIMALS 12 sexually intact yearling Alpine-cross bucks. PROCEDURES Three 5F angiographic catheters of the same length (100 cm) and diameter (0.17 cm) but differing in curvature at the tip were labeled A (straight tip), B (tip bent in 1 place), and C (tip bent in 2 places). During a single anesthetic episode, attempts were made to blindly pass each catheter into the urinary bladder of each goat. Order of catheters used was randomized, and the veterinarian passing the catheter was blinded as to catheter identity. The total number of attempts at catheter passage and the total number of successful attempts were recorded. RESULTS Catheter A was unsuccessfully passed in all 12 goats, catheter B was successfully passed in 8 goats, and catheter C was successfully passed in 4 goats. The success rate for catheter B was significantly greater than that for catheter A; however, no significant difference was identified between catheters B and C or catheters A and C. CONCLUSIONS AND CLINICAL RELEVANCE 2 angiographic catheters were identified that could be successfully, blindly advanced in a retrograde direction into the urinary bladder of healthy sexually intact male goats. Such catheters may be useful for determining urethral patency, emptying the urinary bladder, and instilling chemolysing agents in goats with clinical obstructive urolithiasis.